Articles by Andrew Weiskopf - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Andrew Weiskopf

Andrew Weiskopf


Andrew Weiskopf is director, technical development, Biogen Idec

Defining Critical Quality Attributes for mAb Therapeutic Products
July 1, 2014

Establishing the CQAs of a mAb product by evaluating impact and uncertainty during risk assessment.

ADVERTISEMENT

ADVERTISEMENT

Click here